TickerFactsScreenerDevelopers

Matinas BioPharma Holdings, Inc. (MTNB) — Revenue

Annual figures by fiscal year, from SEC filings.

2018: $119.8K2019: $89.8K2020: $158.3K2021: $33.0K2022: $3.19M2023: $1.10M$1.10M
2018Revenue (USD)2023
Fiscal YearRevenueChange YoY
2023$1.10M-65.6%
2022$3.19M+9560.6%
2021$33.0K-79.2%
2020$158.3K+76.3%
2019$89.8K-25.0%
2018$119.8K—